Ronald van Marion

<i>IDH1</i> and <i>IDH2</i> Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Martin J. van den Bent, Hendrikus J. Dubbink, Yannick Marie et al. · Clinical Cancer Research · 2010 · 380 citations

<i>TMPRSS2:ERG</i> Fusion by Translocation or Interstitial Deletion Is Highly Relevant in Androgen-Dependent Prostate Cancer, But Is Bypassed in Late-Stage Androgen Receptor–Negative Prostate Cancer

Karin G. Hermans, Ronald van Marion, Herman van Dekken et al. · Cancer Research · 2006 · 239 citations

Unique Fusion, Urology, Functional Genomics +14

<i>IDH1</i> mutations in low-grade astrocytomas predict survival but not response to temozolomide

Hendrikus J. Dubbink, Walter Taal, Ronald van Marion et al. · Neurology · 2009 · 187 citations

Verification and Unmasking of Widely Used Human Esophageal Adenocarcinoma Cell Lines

Jurjen J. Boonstra, Ronald van Marion, David G. Beer et al. · JNCI Journal of the National Cancer Institute · 2010 · 128 citations · Full text

IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study

Yunlei Li, Jessica G. C. A. M. Buijs-Gladdines, Kirsten Canté-Barrett et al. · PLoS Medicine · 2016 · 102 citations · Full text